A Clinical Study to assess Effectiveness of Unani formulations in pityriasis versicolor
Phase 2
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2020/06/026209
- Lead Sponsor
- ational Research Institute of Unani Medicine for Skin Disorders Hyderabad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Participants of any sex aged 19-60 years
Participant having any of the sign and symptoms of Bahaq
Hypopigmented macule
Hyperpigmented macule
Erythema
Pruritus on the lesion
Scaling / Desquamation and
Presence of Malassezia furfurin the scrapings of the lesion
Exclusion Criteria
Participant with serious co-morbid medical condition and other fungal infection
Participant who had received any systemic or topical antimycotic therapy within month of start of study
Pregnant or Lactating Women
Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction
Known cases of Immunocompromised states (HIV/ AIDS, etc.)/ Malignancies
Participant not willing to attend treatment schedule regularly
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method